Do analysts rate CRON or ACB?

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Aurora Cannabis 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer CRON or ACB?

In the previous week, Aurora Cannabis had 18 more articles in the media than Cronos Group. MarketBeat recorded 26 mentions for Aurora Cannabis and 8 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.62 beat Aurora Cannabis' score of 0.27 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 5 Very Positive mention(s) 6 Positive mention(s) 6 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts prefer CRON or CGC?

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media refer more to CRON or CGC?

In the previous week, Cronos Group had 3 more articles in the media than Canopy Growth. MarketBeat recorded 8 mentions for Cronos Group and 5 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.71 beat Cronos Group's score of 0.62 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CRON or OGI?

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's higher possible upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Organigram Global 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Do analysts recommend CRON or SNDL?

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than SNDL. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SNDL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger valuation & earnings, CRON or SNDL?

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group $146.59M 8.12 -$9.45M $0.20 16.15 SNDL $677.32M 0.46 -$11.29M -$0.06 N/A

Is CRON or SNDL more profitable?

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets Cronos Group 39.08% 4.85% 4.62% SNDL -2.36% -2.01% -1.67%

Does the media refer more to CRON or SNDL?

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 8 mentions for Cronos Group and 6 mentions for SNDL. Cronos Group's average media sentiment score of 0.62 beat SNDL's score of 0.32 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor TLRY or CRON?

In the previous week, Tilray Brands had 32 more articles in the media than Cronos Group. MarketBeat recorded 40 mentions for Tilray Brands and 8 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.62 beat Tilray Brands' score of 0.31 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 9 Very Positive mention(s) 10 Positive mention(s) 11 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cronos Group (CRON) Competitors

$3.23 +0.01 (+0.31%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$3.22 -0.01 (-0.31%)

As of 10/9/2026 07:58 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? Cronos Group's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Cronos Group compare to Aurora Cannabis?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aurora Cannabis had 18 more articles in the media than Cronos Group. MarketBeat recorded 26 mentions for Aurora Cannabis and 8 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.62 beat Aurora Cannabis' score of 0.27 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	5 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.12	-$9.45M	$0.20	16.15
Aurora Cannabis	$247.82M	1.19	-$88.13M	-$1.41	N/A

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Aurora Cannabis	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a net margin of 39.08% compared to Aurora Cannabis' net margin of -32.26%. Cronos Group's return on equity of 4.85% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Aurora Cannabis	-32.26%	4.37%	3.45%

Cronos Group has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Summary

Cronos Group beats Aurora Cannabis on 13 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Cronos Group (NASDAQ:CRON) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Comparatively, 0.4% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Canopy Growth	-65.33%	-21.91%	-14.34%

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.12	-$9.45M	$0.20	16.15
Canopy Growth	$251.01M	1.48	-$190.29M	-$0.45	N/A

Cronos Group has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

In the previous week, Cronos Group had 3 more articles in the media than Canopy Growth. MarketBeat recorded 8 mentions for Cronos Group and 5 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.71 beat Cronos Group's score of 0.62 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats Canopy Growth on 14 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Comparatively, 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's higher possible upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Organigram Global	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Cronos Group has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Cronos Group has a net margin of 39.08% compared to Organigram Global's net margin of 28.14%. Cronos Group's return on equity of 4.85% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Organigram Global	28.14%	-13.39%	-8.67%

In the previous week, Cronos Group had 7 more articles in the media than Organigram Global. MarketBeat recorded 8 mentions for Cronos Group and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.82 beat Cronos Group's score of 0.62 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Positive
Organigram Global	Very Positive

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.12	-$9.45M	$0.20	16.15
Organigram Global	$185.07M	0.73	-$17.70M	$0.46	2.09

Summary

Cronos Group beats Organigram Global on 10 of the 16 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

Cronos Group (NASDAQ:CRON) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Cronos Group has a net margin of 39.08% compared to SNDL's net margin of -2.36%. Cronos Group's return on equity of 4.85% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
SNDL	-2.36%	-2.01%	-1.67%

8.7% of Cronos Group shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.12	-$9.45M	$0.20	16.15
SNDL	$677.32M	0.46	-$11.29M	-$0.06	N/A

In the previous week, Cronos Group had 2 more articles in the media than SNDL. MarketBeat recorded 8 mentions for Cronos Group and 6 mentions for SNDL. Cronos Group's average media sentiment score of 0.62 beat SNDL's score of 0.32 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SNDL	0 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 28.79%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than SNDL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
SNDL	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Cronos Group beats SNDL on 14 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.53	-$121.40M	-$1.08	N/A
Cronos Group	$146.59M	8.12	-$9.45M	$0.20	16.15

Tilray Brands has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 1.6% of Tilray Brands shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cronos Group has a net margin of 39.08% compared to Tilray Brands' net margin of -16.91%. Cronos Group's return on equity of 4.85% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-16.91%	-10.47%	-7.52%
Cronos Group	39.08%	4.85%	4.62%

Tilray Brands currently has a consensus target price of $5.90, suggesting a potential upside of 66.67%. Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 28.79%. Given Tilray Brands' higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	2 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.38
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Tilray Brands had 32 more articles in the media than Cronos Group. MarketBeat recorded 40 mentions for Tilray Brands and 8 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.62 beat Tilray Brands' score of 0.31 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	9 Very Positive mention(s)	10 Positive mention(s)	11 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cronos Group beats Tilray Brands on 10 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.19B	$12.40B	$7.25B	$13.30B
Dividend Yield	N/A	2.63%	2.52%	22.58%
P/E Ratio	16.15	797.58	275.01	26.14
Price / Sales	8.12	751.21	582.85	87.88
Price / Cash	257.64	86.66	76.96	53.71
Price / Book	1.08	10.71	11.22	6.33
Net Income	-$9.45M	$2.84B	$3.50B	$382.15M
7 Day Performance	0.31%	-0.94%	-0.89%	-1.40%
1 Month Performance	2.87%	-3.67%	-4.02%	-3.35%
1 Year Performance	28.69%	-3.97%	7.13%	1.49%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.6058 of 5 stars	$3.23 +0.3%	$2.30 -28.8%	+28.7%	$1.19B	$146.59M	16.15	610	News Coverage Analyst Upgrade
ACB Aurora Cannabis	1.1331 of 5 stars	$4.46 +13.8%	N/A	-15.3%	$257.64M	$314.07M	N/A	1,028	Trending News High Trading Volume
CGC Canopy Growth	0.7326 of 5 stars	$0.88 +1.0%	N/A	-39.6%	$393.32M	$251.01M	N/A	1,128
OGI Organigram Global	2.5463 of 5 stars	$0.94 -1.7%	N/A	-49.8%	$134.42M	$185.07M	2.04	1,139	Positive News
SNDL SNDL	1.3223 of 5 stars	$1.25 +0.8%	N/A	-51.6%	$319.17M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 10/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Do insiders and institutionals have more ownership in CRON or ACB?

Does the media prefer CRON or ACB?

Which has stronger earnings & valuation, CRON or ACB?

Do analysts rate CRON or ACB?

Is CRON or ACB more profitable?

Which has more risk & volatility, CRON or ACB?

Summary

How does Cronos Group compare to Canopy Growth?

Do insiders & institutionals have more ownership in CRON or CGC?

Is CRON or CGC more profitable?

Which has stronger valuation and earnings, CRON or CGC?

Which has more risk & volatility, CRON or CGC?

Does the media refer more to CRON or CGC?

Do analysts prefer CRON or CGC?

Summary

How does Cronos Group compare to Organigram Global?

Do institutionals & insiders have more ownership in CRON or OGI?

Do analysts recommend CRON or OGI?

Which has more risk & volatility, CRON or OGI?

Is CRON or OGI more profitable?

Does the media prefer CRON or OGI?

Which has preferable earnings & valuation, CRON or OGI?

Summary

How does Cronos Group compare to SNDL?

Is CRON or SNDL more profitable?

Do insiders and institutionals have more ownership in CRON or SNDL?

Which has more volatility and risk, CRON or SNDL?

Which has stronger valuation & earnings, CRON or SNDL?

Does the media refer more to CRON or SNDL?

Do analysts recommend CRON or SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Which has stronger earnings & valuation, TLRY or CRON?

Which has more risk and volatility, TLRY or CRON?

Do institutionals and insiders hold more shares of TLRY or CRON?

Is TLRY or CRON more profitable?

Do analysts prefer TLRY or CRON?

Does the media favor TLRY or CRON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools